2.5mg of tirzepatide Injection at ₹ 3500/vial | Mounjaro in New Delhi Weight Loss - Rejuvenescence Med

The Summary of Product Characteristics states semaglutide is not recommended in patients with severe gastrointestinal disease, including severe gastroparesis

If you cannot use or tolerate minoxidil: Microneedling as monotherapy may be a viable alternative

42 Whilst the evidence from clinical trials is mixed, overall there appears to be a benefit of NAC at a dose of 1200 mg per day alongside triple therapy

PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to identify which patients are more likely to experience cardiovascular side effects, enabling your provider to adjust your starting dose or titration schedule proactively

The FDA granted approval on December 22, 2025, making the Wegovy Pill the first oral GLP-1 specifically indicated for weight loss